111 related articles for article (PubMed ID: 3125614)
1. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use].
Castrillón LE
Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614
[No Abstract] [Full Text] [Related]
2. Immunological activities of muramyl peptides.
Bahr GM; Chedid L
Fed Proc; 1986 Oct; 45(11):2541-4. PubMed ID: 3489642
[TBL] [Abstract][Full Text] [Related]
3. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
[TBL] [Abstract][Full Text] [Related]
4. Target cells for immunomodulatory action of muramyl dipeptide.
Dozmorov IM; Bagaeva LV; Kuzin II; Svirshchevskaya EV
Biomed Sci; 1991; 2(2):193-7. PubMed ID: 1772973
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
Leclerc C; Bourgeois E; Chedid L
Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
[TBL] [Abstract][Full Text] [Related]
6. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
McCoy DM; Brown GL; Ausobsky JR; Polk HC
Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
[TBL] [Abstract][Full Text] [Related]
7. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
Reisser D; Jeannin JF; Martin F
C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
[TBL] [Abstract][Full Text] [Related]
8. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
9. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
10. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
Reisser D; Jeannin JF; Lagadec P; Martin F
J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
Leclerc C; Chedid L
Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
[TBL] [Abstract][Full Text] [Related]
12. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
[TBL] [Abstract][Full Text] [Related]
13. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
14. Modulation of murine lymphoma growth by MDP, MDP(D-D) and cyclophosphamide. 1. Inhibition of growth in vivo.
Phillips NC; Paraf A; Bahr GM; Chedid L
Int J Immunopharmacol; 1983; 5(3):219-27. PubMed ID: 6604705
[No Abstract] [Full Text] [Related]
15. The in situ induction of tumoricidal activity in alveolar macrophages by liposomes containing muramyl dipeptide is a thymus-independent process.
Fidler IJ
J Immunol; 1981 Oct; 127(4):1719-20. PubMed ID: 6974201
[No Abstract] [Full Text] [Related]
16. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of the in vivo dinitrophenyl antibody response to the DNP conjugate of L-glutamic acid60-L-alanine30-L-Tyrosine10 (GAT) polymer by a synthetic adjuvant, muramyl dipeptide (MDP): target cells for adjuvant activity and isotypic pattern of MDP-stimulated response.
Lowy I; Theze J; Chedid L
J Immunol; 1980 Jan; 124(1):100-4. PubMed ID: 6965289
[TBL] [Abstract][Full Text] [Related]
18. Lipophilic muramyl dipeptide-induced changes in electron microscopic morphology and phagocytic function of murine macrophages.
Masihi KN; Ozel M; Lange W; Azuma I
J Biol Response Mod; 1986 Feb; 5(1):20-6. PubMed ID: 3958752
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of murine B-cell tumor growth by MDP, MDP(D-D) and Vaccin is mediated by macrophages.
Moras ML; Phillips NC; Bahr GM; Chedid L
Int J Immunopharmacol; 1985; 7(4):515-24. PubMed ID: 3876296
[TBL] [Abstract][Full Text] [Related]
20. [Epithelioid granuloma formation by a bacterial cell wall constituent. (Part 2)].
Tanaka A
Kekkaku; 1983 Jan; 58(1):39-51. PubMed ID: 6405070
[No Abstract] [Full Text] [Related]
[Next] [New Search]
